Detigon Linctus (100 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Bayer India Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ammonium Chloride, Alcohol,Chlophedianol,Menthol. This drug comes in the form of Linctus. The general packing available for this medicine consists of 110 ml and is priced at Rs 15.95 (arround $0.2233 US Dollar)
The main active ingredients or salts in Detigon Linctus (100 ml) are :
Ammonium Chloride-50 mg
Menthol-0.25 mg
Alcohol-0.35 ml Chlophedianol-20 mg
Ammonium Chloride Indication (Prescribed for or used as):
For more details on Ammonium Chloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ammonium Chloride..
Alcohol Indication (Prescribed for or used as):
For more details on Alcohol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Alcohol..
Chlophedianol Indication (Prescribed for or used as): Antitussive agent. Nasal decongestant.
For more details on Chlophedianol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlophedianol..
Menthol Indication (Prescribed for or used as):
For more details on Menthol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Menthol..
Detigon Linctus (100 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Detigon Linctus (100 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ammonium Chloride-50 mg Menthol-0.25 mg Alcohol-0.35 ml Chlophedianol-20 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.